MyAverix Finance
V · Healthcare
Kane Biotech Inc (KNE)
Biotechnology
Kane Biotech Inc (KNE) is listed on V in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KNE
Kane Biotech Inc (KNE) — FAQ
What is KNE's P/E ratio?
The price-to-earnings (P/E) ratio for Kane Biotech Inc (KNE) is 18.00 (data as of 2026-03-23).
Does Kane Biotech Inc pay a dividend?
Dividend yield is not available in the current snapshot for Kane Biotech Inc (KNE). Check the MyAverix Finance app for the latest dividend data.
What sector is Kane Biotech Inc in?
Kane Biotech Inc (KNE) is classified in the Healthcare sector (Biotechnology industry).
What exchange is KNE listed on?
KNE is listed on V.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.